EVgo deploys 40% of 2025 stations using prefabricated charging skids

EVgo Inc. (NASDAQ: EVGO) deployed more than 40% of its electric vehicle charging stations in 2025 using domestically manufactured prefabricated modular skids, exceeding its year-end goal. The company partnered with Miller Electric Company, a Jacksonville, Florida-based electrical contractor, to reduce installation costs by an average of 15% while accelerating deployment timelines.

The prefabrication process assembles all charging equipment onto a single base frame made from American steel and aluminum at Miller Electric's facility before shipment to installation sites. This approach ensures consistent assembly in a controlled environment and supports domestic manufacturing.

"The prefabrication model is a win-win for EVgo because we can fast-track infrastructure deployment to meet charging demand and support workforce development in this growing industry," said Dennis Kish, President of EVgo.

Miller Electric has scaled capacity at its prefabrication facility and employs more than 1,400 people in the Jacksonville area. The partnership between the companies began in 2023.

EVgo's prefabricated stations are operational in California, Florida, Georgia, Illinois, Nebraska, New York and Texas, with additional stations under development in North Carolina and Utah. The prefabricated stations deployed in 2025 can charge up to 14 vehicles simultaneously and feature 350kW fast chargers.

The prefabrication approach allows integration of customer experience features including Wi-Fi infrastructure, lighting, security cameras, and canopies. EVgo operates more than 1,100 fast charging stations across 47 states.

Miller Electric is a 97-year-old company with 21 branch offices throughout the United States and is part of EMCOR Group Company (NYSE: EME).

You May Also Be Interested In

• SpaceX files for 555.56M share IPO at $135/sh
• Bitmine Immersion Technologies plans $300 million preferred stock offering
• Darling Ingredients receives US patent for blood glucose collagen peptide